Claire Leroy Selected Research

Claire Leroy Research Topics

Disease

6	Epilepsy (Aura) 09/2011 - 04/2002
6	Status Epilepticus (Complex Partial Status Epilepticus) 09/2011 - 10/2002
6	Temporal Lobe Epilepsy 09/2011 - 04/2002
4	Seizures (Absence Seizure) 01/2007 - 04/2003
3	Neuroinflammatory Diseases 01/2021 - 01/2017
3	Cocaine-Related Disorders (Cocaine Addiction) 01/2018 - 04/2008
2	Drug Resistant Epilepsy 11/2023 - 01/2023
2	Schizophrenia (Dementia Praecox) 01/2018 - 01/2017
2	Mental Disorders (Mental Disorder) 01/2018 - 11/2013
1	Partial Epilepsies (Epilepsy, Partial) 11/2023
1	Encephalitis (Encephalitis, Rasmussen) 10/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2022
1	Substance-Related Disorders (Drug Abuse) 12/2021
1	Binge Drinking 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Cataplexy 01/2018
1	Narcolepsy 01/2018
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2018
1	Choriocarcinoma 05/2017
1	Amyloidosis 04/2016
1	Alzheimer Disease (Alzheimer's Disease) 04/2016
1	Disease Progression 04/2016
1	Multiple Sclerosis 10/2015
1	Gliosis 04/2002

Drug/Important Bio-Agent (IBA)

7	LithiumIBA 09/2011 - 04/2002
7	Pilocarpine (Ocusert)FDA LinkGeneric 09/2011 - 04/2002
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2006
3	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 11/2023 - 01/2017
3	Cocaine (Cocaine HCl)IBA 12/2021 - 04/2008
3	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2017
3	Modafinil (Provigil)FDA Link 01/2018 - 04/2008
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2017
2	Buprenorphine (Subutex)FDA LinkGeneric 01/2023 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2023 - 12/2021
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 01/2016
2	BenzodiazepinesIBA 10/2015 - 06/2004
2	Glucose (Dextrose)FDA LinkGeneric 09/2011 - 04/2006
2	Topiramate (Topamax)FDA LinkGeneric 04/2008 - 01/2007
2	Vigabatrin FDA Link 04/2008 - 01/2007
2	Caffeine (No Doz)FDA LinkGeneric 01/2007 - 04/2003
1	nephrinIBA 12/2022
1	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	nalmefene (Revex)FDA Link 01/2021
1	Arachidonic Acid (Vitamin F)IBA 05/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2017
1	N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA 01/2017
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 04/2016
1	Amyloid (Amyloid Fibrils)IBA 04/2016
1	Therapeutic UsesIBA 01/2016
1	Flumazenil (Romazicon)FDA LinkGeneric 10/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2013
1	Monoamine Oxidase (MAO)IBA 11/2013
1	Messenger RNA (mRNA)IBA 09/2011
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2008
1	VaccinesIBA 04/2008
1	Disulfiram (Antabuse)FDA Link 04/2008
1	Baclofen FDA LinkGeneric 04/2008
1	Aripiprazole (Abilify)FDA Link 04/2008
1	GABA AgentsIBA 04/2008
1	S-2-O-carbamoyl-1-o-chlorophenyl-ethanolIBA 01/2007
1	Drinking WaterIBA 01/2007
1	Pregabalin (Lyrica)FDA Link 01/2007
1	Glucose Transporter Type 3IBA 04/2006
1	Pentylenetetrazole (Metrazol)IBA 04/2006
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2006
1	Dihydrotachysterol (AT 10)IBA 04/2006
1	gamma-Aminobutyric Acid (GABA)IBA 06/2004
1	GABA-A Receptors (GABA(A) Receptor)IBA 06/2004
1	NeurosteroidsIBA 06/2004
1	Neuroprotective AgentsIBA 04/2003
1	Glial Fibrillary Acidic ProteinIBA 04/2002

Therapy/Procedure

3	Therapeutics 10/2023 - 01/2018
1	Pain Management 01/2021
1	Immunotherapy 04/2008
1	Drug Therapy (Chemotherapy) 04/2008